New RSV Vaccines: How to best counsel your patients with heart and lung disease
RSV in Older Adults and High-Risk Individuals
Release Date: 10/13/2023
RSV in Older Adults and High-Risk Individuals
Healthcare professionals should consider RSV in the differential diagnosis of patients with respiratory illness, particularly during the RSV season. This is especially important in the inpatient setting to ensure proper isolation precautions for patients who are positive with RSV to avoid the spread of RSV in the healthcare setting. Similar to influenza, strategies to screen patients upon admission for active RSV infection and vaccine eligibility have the potential to reduce the burden of RSV in high-risk patients. To claim CE or MOC credit, visit
info_outlineRSV in Older Adults and High-Risk Individuals
Increases in respiratory syncytial virus (RSV) cases are expected in the upcoming winter seasons. This podcast will discuss the impact of the virus on high-risk patients and the vaccines available to fight these infections. This educational activity is supported by an educational grant from GSK. To claim CE or MOC credit, visit
info_outlineRSV in Older Adults and High-Risk Individuals
The newly approved RSV vaccines have important health implications, particularly for older adults and those at high risk of RSV complications. This podcast will help the healthcare professional identify those patients at highest risk for severe RSV disease and appropriately counsel them prior to vaccination. To claim CE or MOC credit, visit .
info_outline